ZA918023B - Novel p-oxybenzoic acid derivatives,process for the preparation thereof and use thereof as drug - Google Patents
Novel p-oxybenzoic acid derivatives,process for the preparation thereof and use thereof as drugInfo
- Publication number
- ZA918023B ZA918023B ZA918023A ZA918023A ZA918023B ZA 918023 B ZA918023 B ZA 918023B ZA 918023 A ZA918023 A ZA 918023A ZA 918023 A ZA918023 A ZA 918023A ZA 918023 B ZA918023 B ZA 918023B
- Authority
- ZA
- South Africa
- Prior art keywords
- image
- preparation
- acid derivatives
- drug
- oxybenzoic acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 230000000055 hyoplipidemic effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4032037A DE4032037A1 (de) | 1990-10-09 | 1990-10-09 | Neue p-oxibenzoesaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA918023B true ZA918023B (en) | 1992-07-29 |
Family
ID=6415946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA918023A ZA918023B (en) | 1990-10-09 | 1991-10-08 | Novel p-oxybenzoic acid derivatives,process for the preparation thereof and use thereof as drug |
Country Status (15)
Country | Link |
---|---|
US (1) | US5153353A (xx) |
EP (1) | EP0481253B1 (xx) |
JP (1) | JPH0791221B2 (xx) |
KR (1) | KR950004034B1 (xx) |
AT (1) | ATE116281T1 (xx) |
AU (1) | AU640810B2 (xx) |
CA (1) | CA2048355C (xx) |
DE (2) | DE4032037A1 (xx) |
DK (1) | DK0481253T3 (xx) |
EE (1) | EE02938B1 (xx) |
ES (1) | ES2066309T3 (xx) |
GR (1) | GR3015480T3 (xx) |
IE (1) | IE65962B1 (xx) |
PT (1) | PT98614B (xx) |
ZA (1) | ZA918023B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4314175C2 (de) * | 1993-04-29 | 1995-03-30 | Klinge Co Chem Pharm Fab | Modifikation II von Lifibrol |
DE4414537A1 (de) * | 1994-04-26 | 1995-11-02 | Klinge Co Chem Pharm Fab | Kombinationspräparate mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem HMG-CoA-Reduktase-Hemmer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4109013A (en) * | 1974-12-20 | 1978-08-22 | Klinge Pharma Gmbh & Co. | Substituted propanol-(2) derivatives of hydroxamic acids and the use thereof as hypolipemic drugs |
DE2460689C3 (de) * | 1974-12-20 | 1980-06-26 | Klinge Pharma Gmbh & Co, 8000 Muenchen | 13-disubstituierte Propanol-(2)-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE2735856A1 (de) * | 1977-08-09 | 1979-02-22 | Klinge Co Chem Pharm Fab | Neue 1,3-diphenoxypropan-2-on-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3326164A1 (de) * | 1983-07-20 | 1985-01-31 | Klinge Pharma GmbH, 8000 München | Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
EP0286703A1 (de) * | 1987-04-14 | 1988-10-19 | Klinge Pharma GmbH | Neue Benzoesäure-Derivate, sowie Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1990
- 1990-10-09 DE DE4032037A patent/DE4032037A1/de not_active Withdrawn
-
1991
- 1991-08-02 CA CA002048355A patent/CA2048355C/en not_active Expired - Fee Related
- 1991-08-08 US US07/742,600 patent/US5153353A/en not_active Expired - Fee Related
- 1991-08-08 PT PT98614A patent/PT98614B/pt active IP Right Grant
- 1991-08-13 AU AU82416/91A patent/AU640810B2/en not_active Ceased
- 1991-09-16 KR KR1019910016133A patent/KR950004034B1/ko not_active IP Right Cessation
- 1991-09-25 DE DE59104058T patent/DE59104058D1/de not_active Expired - Fee Related
- 1991-09-25 DK DK91116325.1T patent/DK0481253T3/da active
- 1991-09-25 AT AT91116325T patent/ATE116281T1/de active
- 1991-09-25 ES ES91116325T patent/ES2066309T3/es not_active Expired - Lifetime
- 1991-09-25 EP EP91116325A patent/EP0481253B1/de not_active Expired - Lifetime
- 1991-10-01 IE IE345391A patent/IE65962B1/en not_active IP Right Cessation
- 1991-10-08 ZA ZA918023A patent/ZA918023B/xx unknown
- 1991-10-08 JP JP3260387A patent/JPH0791221B2/ja not_active Expired - Lifetime
-
1994
- 1994-11-16 EE EE9400290A patent/EE02938B1/xx unknown
-
1995
- 1995-03-20 GR GR950400611T patent/GR3015480T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR950004034B1 (ko) | 1995-04-22 |
EE02938B1 (et) | 1996-08-15 |
AU8241691A (en) | 1992-06-11 |
DE59104058D1 (de) | 1995-02-09 |
CA2048355C (en) | 1997-11-18 |
DE4032037A1 (de) | 1992-04-16 |
KR920007977A (ko) | 1992-05-27 |
IE65962B1 (en) | 1995-11-29 |
ES2066309T3 (es) | 1995-03-01 |
ATE116281T1 (de) | 1995-01-15 |
GR3015480T3 (en) | 1995-06-30 |
AU640810B2 (en) | 1993-09-02 |
EP0481253A2 (de) | 1992-04-22 |
DK0481253T3 (da) | 1995-05-22 |
PT98614B (pt) | 1999-01-29 |
JPH04273846A (ja) | 1992-09-30 |
PT98614A (pt) | 1992-06-30 |
US5153353A (en) | 1992-10-06 |
EP0481253B1 (de) | 1994-12-28 |
JPH0791221B2 (ja) | 1995-10-04 |
IE913453A1 (en) | 1992-04-22 |
EP0481253A3 (en) | 1992-10-21 |
CA2048355A1 (en) | 1992-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU83786A (en) | Process for obtaining hypoglicemic thiazolidindione | |
GR3004925T3 (xx) | ||
AU8976291A (en) | New 1,4-disubstituted piperazines, process for the preparation thereof, and pharmaceutical compositions containing them | |
DE3265425D1 (en) | S-adenosylmethionine derivatives, the process for their preparation and therapeutic compositions which contain them as active principle | |
AU581442B2 (en) | 2-substituted-1, 3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them | |
AU582235B2 (en) | Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs | |
EP0387821A3 (de) | 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel | |
ZA918023B (en) | Novel p-oxybenzoic acid derivatives,process for the preparation thereof and use thereof as drug | |
IE873212L (en) | Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor | |
GR860679B (en) | Novel 3-pyridylmethylnaphthyl derivatives method for their preparation and their use as medicine | |
DE3378120D1 (en) | Thiazaspiro derivatives, process for their preparation and pharmaceutical composition | |
PH24258A (en) | Substituted quinoxyalyl-imidazolidine-2,4-diones,their use as medicaments and pharmaceutical preparation | |
HUT44802A (en) | Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them | |
HUT37924A (en) | Process for production of derivatives of n-byciclohepthil-byciclohepthenil-alkyl-imidazol and medical preparatives containing therof | |
AU1929588A (en) | Leukotriene antagonists, a process for the preparation thereof, and the use thereof for the treatment of diseases | |
KR900014372A (ko) | 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제 | |
GR3001809T3 (en) | Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments | |
FI882979A (fi) | Mikrobiologinen menetelmä 4'-13(S)-dihydro-4'-jodidoksorubisiinin valmistamiseksi |